Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

SEBIPROX 15 MG/G CHAMPU - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/SEBIPROX 15 MG/G CHAMPU

Approved

STANDARD

SEBIPROX 15 MG/G CHAMPU

Gsk-Gebro Consumer Healthcare Gmbh🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Jan 30, 2024
Approval ID: 41235bc5d8e6ca02
Company: Gsk-Gebro Consumer Healthcare Gmbh
Type: Standard

Approval Details

Approval Id: 41235bc5d8e6ca02
Drug Cima Aemps Name: SEBIPROX 15 MG/G CHAMPU
Register Number: 1-24293IP3
Holder Company Name: Gsk-Gebro Consumer Healthcare Gmbh
Marketing Company Name: Ecofar Productos S.L.
Authorization Date: 2024-01-30
Dosage Form: CHAMPÚ
Dose: 1,5 %
Route Of Administration: USO CUTÁNEO
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: No
Company Name: Gsk-Gebro Consumer Healthcare Gmbh

Active Ingredients

CICLOPIROX OLAMINA

15 mg/g

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jan 30, 2024

Approval ID

41235bc5d8e6ca02

Type

Standard

Back to CIMA-AEMPS Approvals